Showing results (161-170 of 489) with videos related to

Sort By:
Pageof 49
Occupational and Environmental Medicine|October 1, 1995
Platinum salt sensitivity in refinery workers: incidence and effects of smoking and exposureA E Calverley, D Rees, R J Dowdeswell, et al.
The European Respiratory Journal|February 7, 2003
Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbationsP W Jones, L R Willits, P S Burge, et al.
American Journal of Respiratory and Critical Care Medicine|September 17, 2005
Lung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary diseaseNicola J Stevenson, Paul P Walker, Richard W Costello, et al.
Platelets|January 20, 2006
Platelet FcgammaRIIA expression is associated with the alpha2 integrin C807T gene polymorphism in type 2 diabetesDavid C Calverley, Lyndy V Baldermann, Kathleen Moran, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 1, 2007
The severity of airways obstruction as a determinant of treatment response in COPDPeter Calverley, Romain A Pauwels, Paul W Jones, et al.
Respiratory Medicine|August 12, 2008
Identifying COPD patients at increased risk of mortality: predictive value of clinical study baseline dataDavid M G Halpin, Stefan Peterson, Thomas P Larsson, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 30, 2017
Prevention of Exacerbations in Chronic Obstructive Pulmonary Disease: Knowns and UnknownsAlvar Agustí, Peter M Calverley, Marc Decramer, et al.
Thorax|March 1, 1994
Respiratory effort perception at rest and during carbon dioxide rebreathing in patients with dystrophia myotonicaJ E Clague, J Carter, J Coakley, et al.
Annals of the American Thoracic Society|September 29, 2017
The Effect of Defining Chronic Obstructive Pulmonary Disease by the Lower Limit of Normal of FEV<sub>1</sub>/FVC Ratio in Tiotropium Safety and Performance in Respimat ParticipantsPeter M A Calverley, Achim Mueller, Andrew Fowler, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 23, 2006
Platelet FcgammaRIIA receptor surface expression is increased in patients with ESRD and is associated with atherosclerotic cardiovascular eventsMohamed El-Shahawy, Mazen Noureddin, Hesham Abdullah, et al.
Pageof 49